Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04072198 |
| Title | Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients (NIVACOR) |
| Acronym | NIVACOR |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Gruppo Oncologico Italiano di Ricerca Clinica |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Istituto Ospedaliero Fondazione Poliambulanza | Brescia | Italy | Details | |||
| Arnas Garibaldi | Catania | Italy | Details | |||
| Azienda Ospedaliero-Universitaria Careggi | Florence | Italy | Details | |||
| Istituto Nazionale Tumori Fondazione G.Pascale | Napoli | Italy | Details | |||
| Istituto Oncologico Veneto | Padua | Italy | Details | |||
| AUSL/IRCCS di Reggio Emilia | Reggio Emilia | Italy | Details | |||
| Policlinico Universitario Campus Bio-Medico | Roma | Italy | Details | |||
| IRCCS - Casa Sollievo della Sofferenza | San Giovanni Rotondo | Italy | Details |